Effects of Posttrial Antihypertensive Drugs on Morbidity and Mortality: Findings from 15-Year Passive Follow-Up after ALLHAT Ended.

Xianglin L DuLara M SimpsonBrian C TandyJudy BettencourtBarry R Davis

Published in: International journal of hypertension (2021)

After the conclusion of the ALLHAT, almost all patients switched to combination antihypertensive therapies, independently by the original drug class, and the combination therapies (mostly based on diuretics) reduced the incidence of major cardiovascular outcomes and mortality.

Keyphrases

blood pressure
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
cardiovascular events
emergency department
patient reported outcomes